Steven Woloshin, MD, MS
Professor of Medicine and of Community & Family Medicine
Co-Director, Medicine in the Media Program
Dartmouth Institute for Health Policy & Clinical Practice
Areas of Expertise
Dr. Woloshin's research interest is in learning how to enhance the quality of medical communication to the public, patients, physicians and policymakers. His work (in collaboration with Dr. Lisa Schwartz) has 2 main approaches: improving the quality of messages presenting health information to people, and preparing audiences to make sense of the messages they receive. His main focus is on the communication of medical statistics and information about the benefits and harms of screening and prescription drugs.
2013 - The electronic version, "Know Your Chances" co-authored with Lisa Schwartz, was selected to be included on the National Library of Medicine Bookshelf
Medical Communication Companies and Continuing Medical Education - Clouding the Sunshine?
JAMA, Dec. 18, 2013;Vol. 310, No. 23:
Low “T” as in “Template”: How to Sell Disease
JAMA Internal Medicine, June 3, 2013;1-3. doi:10.1001:
How A Charity Oversells Mammography
BMJ, August 2012;
Too little? Too much? Primary care physicians' view on US Health Care
Arch of Internal Medicine, 2011;171:
Cancer Screening Campaigns — Getting Past Uninformative Persuasion
N. Engl J Medicine, Nov. 1, 2012;
Changing disease definitions: Implications on disease prevalence.
Eff Clin Pract , 1999;Vol. 2:
The role of numeracy in understanding the benefit of screening mammography
Ann Intern Med, 1997;127:
Enthusiasm for cancer screening in the United States
Communicating drug benefits and harms with the drug facts box: Two randomized trials.
Ann Intern Med , 2009;150:
Lost in transmission – FDA drug information that never reaches clinicians.
N Engl J Med , 2009;Vol.316:
In the Media
‘Low T’ and the Peril of Medicating Grumpy Old Men
LA Times, February 16, 2014 »
The Big T Medicine Show
The Economist, February 24, 2014 »
Is ‘Low T’ A Real Illness Or Just Pharma Windfall?
Huffington Post, February 5, 2014 »
Weighing Testosterone’s Benefits and Risks
New York Times, February 3, 2014 »
NPR, February 6, 2014 »
Drug Industry Favors Companies for Doctors’ Education Grants
Bloomberg News, December 18, 2013 »
Big Questions About Testosterone Treatment For Men
NPR, June 4, 2013 »
Health task force challenges conventions, faces condemnation
USA Today, July 14, 2012 »
Think Inside The Box
New York Times Op-Ed, July 5, 2011 »
TV not always a healthy channel for advice
Los Angeles Times, July 14, 2012 »